| |
| Monday, 3 October 2022 |
| 08:00 - 12:00 | ICNA Executive Board (2018 - 2022) Meeting (Zeytin 2) |
| 12:00 - 18:00 | Registration |
| 12:00 - 17:30 | Genç meraklılar için Pediatrik nöromusküler hastalıklar kursu [A Half Day Pediatric Neuromuscular Disorders course for the young enthusiast] (Course in Turkish) (Kardelen 1 & 2) |
| | TÜRKİYE ÇOCUK NÖROLOJİSİ DERNEĞİ SEMPOZYUMU (TCNA SYMPOSIUM) - Program in Turkish (Orkide 3) |
| 13:00 - 16:30 | ICNA Executive Board (2022-2026) Meeting (Zeytin 2) |
| |
| Tuesday, 4 October 2022 |
| 07:00 - 08:00 | Rise and Shine Seminars |
| | Brain on fire: neurologic manifestations of COVID (Kardelen 1 & 2) |
| | Fetal neurology – diagnosis and counseling (Orkide 4) |
| | Movement disorders in childhood - Video Session: Illustrative Case Presentations (Orkide 3) |
| | Perspectives from Low Resource Settings (Kardelen 3 & 4) |
| 08:00 - 08:45 | Plenary session |
| | The mTOR pathway: A treatable target and updates in tuberous sclerosis complex (Orkide 1 & 2) |
| 08:45 - 09:30 | Plenary session |
| | Risk for infantile spasms after acute symptomatic neonatal seizures (Orkide 1 & 2) |
| 09:30 - 10:00 | Coffee Break / Registration |
| 10:00 - 12:00 | Parallel Symposia |
| | New treatment opportunities in genetic neuromuscular disorders (Orkide 3) |
| | Cerebral palsy in the genomic era (Orkide 4) |
| | Neonatal seizures: new horizons (Kardelen 1 & 2) |
| | Orphans without borders: personalized medicine and international collaboration in rare diseases (Kardelen 3 & 4) |
| 12:00 - 13:00 | ICNA Annual General Meeting (Orkide 4) |
| 13:00 - 14:00 | Industry Symposia |
| | PTC symposium| AADC deficiency: diagnosis and management (Orkide 3) |
| | Zogenix | From evidence to clinical practice: Navigating the diagnosis and management of Dravet syndrome (Kardelen 1 & 2) |
| | BioMarin Symposium | The urgency of diagnosing paediatric epilepsy in the era of precision medicine (Kardelen 3 & 4) |
| 14:00 - 16:00 | Platform Paper Presentations |
| | Epilepsy I (Orkide 3) |
| | Neonatal Neurology and Epilepsy (Orkide 4) |
| | Neurogenetics I (Kardelen 1 & 2) |
| | Neurometabolic (Kardelen 3 & 4) |
| | Education / Neuropsychiatry / Traumatic brain injury (Kardelen 5) |
| 16:00 - 16:30 | Coffee Break |
| 16:30 - 17:30 | Supervised Poster Tours |
| 17:30 - 18:30 | Controversies in Child Neurology: Debates |
| | How aggressive should treatment be for ECSWS? (Orkide 1 & 2) |
| | Refractory status epilepticus : Sequential use of ASMs versus Early use of anesthetics? (Orkide 1 & 2) |
| | Is clinical phenotyping still important in the genomic era? (Orkide 1 & 2) |
| 18:30 - 19:30 | Dinner |
| 20:00 - 21:00 | Opening Ceremony |
| |
| Wednesday, 5 October 2022 |
| 06:00 - 07:00 | Congress Morning Activities |
| 07:00 - 08:00 | Rise and Shine Seminars |
| | Doose, MAE, EMAS, IGE, DEE and now Delphi ? What is the BUZZ all about? (Orkide 3) |
| | Neurofibromatosis type I – myriad neurological manifestations, recent diagnostic criteria and evolving treatment options (Kardelen 1 & 2) |
| | The current status and future of AAV mediated gene therapy in pediatric neuromuscular and neurological disorders (Orkide 4) |
| 08:00 - 08:45 | Congenital myasthenic syndromes: An update (Orkide 1 & 2) |
| 08:45 - 09:30 | The Charcuterie board of child neurology - Indian Flavours (Orkide 1 & 2) |
| 09:30 - 10:00 | Coffee Break |
| 10:00 - 12:00 | Parallel Symposia |
| | Neurocognitive disabilities in developmental and epileptic encephalopathies - Can we do better ? (Orkide 3) |
| | Cerebral palsy diagnosis and treatment in the 2020’s – global perspective (Orkide 4) |
| | Pediatric stroke: time lost is brain lost (Kardelen 1 & 2) |
| | Treatable vitamin- and/or cofactor-responsive neurometabolic disorders which must not be missed (Kardelen 3 & 4) |
| 12:00 - 13:00 | Future Leaders of ICNA Symposium (Orkide 4) |
| 14:00 - 16:00 | Platform Paper Presentations |
| | Epilepsy II (Orkide 1 & 2) |
| | Neuromuscular (Orkide 3) |
| | Autism Spectrum/ Neurodevelopmental / ADHD (Orkide 4) |
| | Movement disorders/ Neurometabolic/ Neurogenetics (Kardelen 1 & 2) |
| | Headache / Stroke (Kardelen 3 & 4) |
| | CNS infections / Neurooncology (Kardelen 5) |
| 16:00 - 16:30 | Coffee Break |
| 16:30 - 17:30 | Supervised Poster Tours |
| 17:30 - 18:30 | Controversies in Child Neurology: Debates |
| | When would you counsel a family about the risk of SUDEP? (Orkide 1 & 2) |
| | Is it the low carbohydrate or high fat that does the work in the ketogenic diet for the treatment of epilepsy? (Orkide 1 & 2) |
| | Do we need EEG rather than aEEG to improve outcome in neonates? (Orkide 1 & 2) |
| 18:30 - 19:30 | Dinner |
| | Soccer Match |
| 19:30 - 21:30 | EPNS Symposium & Master Classes |
| | EPNS Symposium - Delineation of novel disease entities in child neurology (Orkide 3) |
| | Improving diagnosis and treatment in childhood epilepsies (Orkide 4) |
| | Neonatal imaging in times of precision medicine (Kardelen 1 & 2) |
| | Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies (Kardelen 3 & 4) |
| 21:00 - 23:00 | Evening Program (Twilight in Antalya) |
| 21:30 - 22:00 | Evening Program |
| |
| Thursday, 6 October 2022 |
| 06:00 - 07:00 | Congress Morning Actitivites |
| 07:00 - 08:00 | Rise and Shine Seminars |
| | A practical guide to the diagnosis and treatment of rare neurogenetic diseases (Orkide 3) |
| | Neuronal ceroid lipofuscinoses: natural history, phenotypic spectrum, management and emerging treatments (Orkide 4) |
| | The essentials of neuro-palliative care in children (Kardelen 1 & 2) |
| 08:00 - 08:45 | Plenary session |
| | Using your brain differently: Modulating developmental plasticity toward better outcomes from perinatal brain injury (Orkide 1 & 2) |
| 08:45 - 09:30 | Prichard Award Lecture |
| | The impact of epilepsies on brain development and function (Orkide 1 & 2) |
| 09:30 - 10:00 | Coffee Break |
| 10:00 - 12:00 | Parallel Symposia |
| | Movement disorders in children: a case-based approach (Orkide 3) |
| | A GLYMPSE into the disorders of CSF circulation in children (Orkide 4) |
| | Epilepsy networks: seizures, surgery and neuronal plasticity (Kardelen 1 & 2) |
| | Promises and challenges in the diagnosis, translational research, and therapies for neuromuscular diseases in children and adolescents (Kardelen 3 & 4) |
| 13:00 - 14:00 | ICNTN Symposium (Orkide 1 & 2) |
| | Jazz Pharma Symposium: Developmental Epileptic Encephalopathies in The Genomic Era: From Concepts to Precision Medicine (Orkide 4) |
| | Nestlé Symposium: Nutrition in Children with Cerebral Palsy: The Issues and Solutions (Orkide 3) |
| | Pediatric Neurohospitalist Special Interest Group (SIG) Meeting (Kardelen 1 & 2) |
| 14:00 - 16:00 | Platform Paper Presentations |
| | Epilepsy III (Orkide 1 & 2) |
| | Neurogenetics II (Orkide 3) |
| | Neuroimmunology (Orkide 4) |
| | Movement disorders (Kardelen 1 & 2) |
| | Neuroradiology/Neurovascular disorders/CP and Neurorehabilitation (Kardelen 3 & 4) |
| 16:00 - 16:30 | Coffee Break |
| 16:30 - 17:30 | Supervised Poster Tours |
| 17:30 - 19:30 | Workshop on AI |
| | Clinical applications of artificial intelligence in pediatric neurosciences (Free Pre-Registration required) (Orkide 3) |
| 17:30 - 18:30 | Global Burden of Diseases Symposium |
| | The global situation of child neurology - from a Consultant & Resident's perspective (Orkide 1 & 2) |
| 18:30 - 19:30 | Symposium |
| | Screen time in children: Pros and Cons and recommended guidelines (Orkide 1 & 2) |
| 19:00 - 23:00 | Networking |
| 21:00 - 23:00 | Gala Festivities |
| |
| Friday, 7 October 2022 |
| 07:00 - 08:00 | Rise and Shine Seminars |
| | Functional neurological movement disorders in childhood- updates and novel phenotypes, proposals for management and influence during the COVID pandemic (Orkide 3) |
| | Humanism in child neurology: east or west – two sides of the same coin (Orkide 4) |
| | Sleep and migraine: from pathophysiology to clinical aspects (Kardelen 1 & 2) |
| | Updates on advances in infantile spasms syndrome (Orkide 1 & 2) |
| 08:00 - 08:45 | Plenary session |
| | Making sense of autoimmune encephalitis (Orkide 1 & 2) |
| 08:45 - 09:30 | Wallace Award Lecture |
| | The developmental and epileptic encephalopathies in low resource settings: Challenges in diagnosis and management (Orkide 1 & 2) |
| 09:30 - 10:00 | Coffee Break |
| 10:00 - 12:00 | Parallel Symposia |
| | Autism spectrum disorder – current concepts and future prospects (Orkide 1 & 2) |
| | Inborn errors of metabolism presenting with movement disorders: how should they be recognized, diagnosed and treated? (Orkide 3) |
| | Advances and challenges in the delivery of care for children diagnosed with status epilepticus (Orkide 4) |
| | Neuronal plasticity in developing brain: non-invasive brain stimulation modalities (Kardelen 1 & 2) |
| 12:00 - 13:00 | Lunch |
| 13:00 - 14:00 | Closing Ceremony (Orkide 1 & 2) |
| 14:00 - 16:00 | Workshops |
| | Research design methodology workshop including challenges in resource-limited and resource-rich settings (Orkide 3) |
| | Simplifying mitochondrial disorders for pediatric neurologists (Orkide 4) |
